<DOC>
	<DOCNO>NCT01033565</DOCNO>
	<brief_summary>The purpose research see effect ( good bad ) Melatonin CR sleep 4-8 year old child autism spectrum disorder sleep problem .</brief_summary>
	<brief_title>Melatonin CR Treatment Impaired Sleep Maintenance 4-8 Year Old Children With Autism Spectrum Disorders</brief_title>
	<detailed_description>The title acute , open-label pilot study `` Controlled Release Melatonin ( Melatonin CR ) treatment impaired sleep maintenance ( ISM ) 4-8 year old child autism spectrum disorder ( ASD ) . '' Maintenance sleep significant challenge treatment child neurodevelopmental disability include ASDs . Night awaken early morning wake detrimental effect child 's daytime behavior function household . Sleep problem ASD population generally manage first behavioral intervention , successful , pharmacologic therapy . Most medication effect sleep onset sleep maintenance . This study investigate effectiveness Melatonin CR manage ISM 4-8 year old child ASD . Twenty patient recruited Developmental/Behavioral Pediatrics Clinic Munroe Meyer Institute University Nebraska Medical Center . Inclusion criterion male female child age 4-8 year diagnosis ASD , include Pervasive Developmental Disorder NOS ( PDD , NOS ) , Asperger 's Syndrome , Autistic Disorder , parent/guardian consent participation , stable psychotropic medication treatment least 4 week , document history ISM base parent-report , somnolog Child Sleep Habits Questionnaire ( CSHQ ) , clinician rating â‰¥4 ( moderately ill ) Clinical Global Impression-Severity ( CGI-S ) Scale . Patients exclude treated Melatonin Melatonin CR past month , fail treatment Melatonin CR , previously un-evaluated medical condition may cause ISM . Following completion somnolog standardize questionnaire , patient treat 10-14 day melatonin CR . Somnologs complete treatment , standardized parent questionnaire , CGI-S , adverse event collection repeat end Melatonin CR therapy . Response define Clinical Global Impression-Improvement ( CGI-I ) score 1 2 ( much much improve ) . These compare baseline rating . Following completion study protocol , patient continue follow Developmental Pediatrics clinic . Data acute pilot trial use evaluate appropriateness large study determine optimal therapy patient ASD ISM .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Male female child , age 48 year , diagnose ASD , include Pervasive Developmental Disorder NOS ( PDD , NOS ) , Asperger 's Syndrome , Autistic Disorder , follow Munroe Meyer Developmental Pediatrics Clinic . Documented impaired sleep maintenance ( ISM ) base parentreport 7 day somnolog ( sleep diary ) . Clinician rating 4 ( moderately ill ) bad CGIS . Rating base clinician 's experience evaluate treat patient population . Previous discussion clinic appointment sleep difficulty , include review sleep hygiene basic behavioral interventions/strategies . Current problem overnight awakening record Children 's Sleep Habits Questionnaire ( CSHQ ) despite behavioral intervention . Stable psychotropic medication treatment past 4 week . Treatment Melatonin Melatonin CR past month previous fail treatment Melatonin CR . Presence previously unevaluated medical condition may etiology nighttime awakening . There contraindication use Melatonin CR patient obstructive sleep apnea .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Impaired sleep maintenance</keyword>
	<keyword>Autism Spectrum Disorders</keyword>
	<keyword>Pediatric</keyword>
</DOC>